BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jihwaprani MC, Sula I, Charbat MA, Haider KH. Establishing delivery route-dependent safety and efficacy of living biodrug mesenchymal stem cells in heart failure patients. World J Cardiol 2024; 16(6): 339-354 [PMID: 38993584 DOI: 10.4330/wjc.v16.i6.339]
URL: https://www.wjgnet.com/1949-8462/full/v16/i6/339.htm
Number Citing Articles
1
Peng Li. Comparative breakthrough: Umbilical cord mesenchymal stem cells <i>vs</i> bone marrow mesenchymal stem cells in heart failure treatmentWorld Journal of Cardiology 2024; 16(12): 776-780 doi: 10.4330/wjc.v16.i12.776
2
Moaz Safwan, Mariam Safwan Bourgleh, Mohamed Aldoush, Khawaja Husnain Haider. Tissue-source effect on mesenchymal stem cells as living biodrugs for heart failure: Systematic review and meta-analysisWorld Journal of Cardiology 2024; 16(8): 469-483 doi: 10.4330/wjc.v16.i8.469